cabozantinib,avelumab,atezolizumab
exelixis,merck,pfizer,roche
['main-cav', 'cosmic021', 'avelumab']
phenomenal rocks the stage with cosmic021 trial data on cabo/atezo: combo was feasible (ae noted) &amp; has activity justifying ongoing main-cav phase 3 maintenance trial (cabo/avelumab) although in a different tx setting #asco22 
Oncologist, Associate Prof, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch, SCCA; views mine